Related references
Note: Only part of the references are listed.British HIV Association guidelines for the management of HIV infection in pregnant women 2012 (2014 interim review)
Annemiek de Ruiter et al.
HIV MEDICINE (2014)
Safety of darunavir/ritonavir (DRV/r) in HIV-1-infected DRV/r-experienced and -naive patients: analysis of data in the real-world setting in Italy
Andrea Antinori et al.
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (2014)
Gestational Diabetes Mellitus in HIV-Infected and -Uninfected Pregnant Women in Cameroon
Jennifer Jao et al.
DIABETES CARE (2013)
Gestational diabetes mellitus in a cohort of HIV-1 infected women
M. I. Gonzalez-Tome et al.
HIV MEDICINE (2008)
Protease inhibitor-based antiretroviral therapy and glucose tolerance in pregnancy: AIDS Clinical Trials Group A5084
Jane Hitti et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2007)
Effects of atazanavir/ritonavir and lopinavir/ritonavir on glucose uptake and insulin sensitivity:: demonstrable differences in vitro and clinically
Mustafa A. Noor et al.
AIDS (2006)
,Effect of protease inhibitor therapy on glucose intolerance in pregnancy
Jennifer H. Tang et al.
OBSTETRICS AND GYNECOLOGY (2006)
Improved obstetric outcomes and few maternal toxicities are associated with antiretroviral therapy, including highly active antiretroviral therapy during pregnancy
RK Tuomala et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2005)
Universal vs. risk factor-based screening for gestational diabetes mellitus: detection rates, gestation at diagnosis and outcome
ME Griffin et al.
DIABETIC MEDICINE (2000)
Share Paper
